DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Rinella ME, Trotter JF, Abdelmalek MF. et al.
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis.
J Hepatol 2019;
70 (04) 735-744
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.